SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Paul Hofman

Paul Hofman

Université Côte d'Azur / CHU Nice (Pasteur Hospital), Nice

Prof. Paul Hofman is Professor of Pathology at Université Côte d’Azur and CHU Nice in Nice, France, where he heads the Laboratory of Clinical and Experimental Pathology at Pasteur Hospital. His research centers on lung cancer pathophysiology and the discovery of predictive and prognostic biomarkers in both tissue and liquid biopsies, and he directs the Nice University Biobank and the city’s Liquid Biopsy Center. He is founding director of the IHU RespirERA and the FHU OncoAge, chairs the Pulmonary Pathology Working Group of the European Society of Pathology, and co-chairs the IASLC Molecular Pathology Working Group. He is a frequent speaker at major international thoracic oncology congresses.

Connect

Paul Hofman

Featured in

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates